Abeona Therapeutics Inc (NASDAQ:ABEO)
| 4.22 Delayed Data As of 4:00pm ET |  +0.29 / +7.38%Today’s Change | 2.19 Today|||52-Week Range 5.80 | +37.01% Year-to-Date |
Latest ABEO News | Press Releases
No recent news for Abeona Therapeutics Inc.
Today’s Trading
| Previous close | 3.93 |
| Today’s open | 3.84 |
| Day’s range | 3.84 - 4.50 |
| Volume | 10,622 |
| Average volume (3 months) | 164,461 |
| Market cap | $96.1M |
Data as of 4:00pm ET, 09/29/2023
Growth & Valuation
| Earnings growth (last year) | +74.36% |
| Earnings growth (this year) | +55.24% |
| Earnings growth (next 5 years) | +2.00% |
| Revenue growth (last year) | -52.87% |
| P/E ratio | NM |
| Price/Sales | 17.12 |
| Price/Book | 2.57 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| DMACDiaMedica Therapeuti... | +0.02 | +0.78% |
| --W World Corp | 0.00 | 0.00% |
| ORMPOramed Pharmaceutica... | +0.10 | +3.98% |
| GLYCGlycoMimetics Inc | -0.10 | -6.37% |
Data as of 4:00pm ET, 09/29/2023
Financials
| Next reporting date | November 13, 2023 |
| EPS forecast (this quarter) | -$0.56 |
| Annual revenue (last year) | $1.4M |
| Annual profit (last year) | -$39.7M |
| Net profit margin | -2,807.36% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cleveland, Ohio |
Forecasts
